Slide 1 Slide 1 Slide 1





Hexal, a Division of the Novartis group, is a global leader in the field of generic pharmaceuticals, offering a wide array of high-quality, affordable products that are no longer protected by valid and enforceable third-party patents. Key product groups include cardiovascular medicines, anti-infectives, treatments for central nervous system and alimentary tract disorders, oncology and respiratory therapies, as well as medications for blood and blood forming organ disorders. Some of the products include Triamhexal, Ciprohexal, Dexahexal.

In This Section Skip Navigation Links.

Stay Connected

Enter your email below to receive our free newsletter.